Month: May 2021

T lymphocytes in hepatocellular carcinoma immune microenvironment: insights into human immunology and immunotherapy

T lymphocytes in hepatocellular carcinoma immune microenvironment: insights into human immunology and immunotherapy

Hepatocellular carcinoma (HCC) is characterised by poor end result and exhibits restricted drug-response in medical trials. Tumor immune microenvironment (TIME) exerts a robust choice strain on HCC, resulting in HCC evolvement and recurrence after a number of therapies. T cell-mediated immunoreaction throughout most cancers surveillance and clearance is central in most cancers immunity. Heterogenous T …

T lymphocytes in hepatocellular carcinoma immune microenvironment: insights into human immunology and immunotherapy Read More »